Leit í EES-gagnagrunni
Commission Implementing Decision (EU) 2023/1155 of 9 June 2023 on the unresolved objections regarding the terms and conditions of the authorisation of the biocidal product Rapid Pro referred by France in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2023/1145 of 7 June 2023 amending Implementing Decision (EU) 2022/2333 concerning certain emergency measures relating to sheep pox and goat pox in Spain
Commission Implementing Regulation (EU) 2023/1144 of 9 June 2023 granting a Union authorisation for the single biocidal product ‘Bacticid IPA-N’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Regulation (EU) 2023/1143 of 9 June 2023 granting a Union authorisation for the single biocidal product ‘Chemisept IPA-N’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Regulation (EU) 2023/1141 of 1 June 2023 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health
Reglugerð framkvæmdastjórnarinnar (ESB) 2023/1141 frá 1. júní 2023 um synjun leyfis fyrir tilteknum heilsufullyrðingum er varða matvæli og vísa hvorki til minnkunar á sjúkdómsáhættu né til þroskunar eða heilbrigðis barna
Commission Implementing Regulation (EU) 2023/1133 of 8 June 2023 granting a Union authorisation for the single biocidal product ‘Superficid express’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Regulation (EU) 2023/1120 of 7 May 2023 granting a Union authorisation for the single biocidal product “APESIN Handaktiv” in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Regulation (EU) 2023/1119 of 12 January 2023 laying down implementing technical standards for the application of Directive (EU) 2019/2034 of the European Parliament and of the Council with regard to standard forms, templates and procedures for the information sharing between the competent authorities of home and host Member States
Commission Implementing Regulation (EU) 2023/1110 of 6 June 2023 amending Implementing Regulation (EU) 2019/1793 on the temporary increase of official controls and emergency measures governing the entry into the Union of certain goods from certain third countries implementing Regulations (EU) 2017/625 and (EC) No 178/2002 of the European Parliament and of the Council
Commission Implementing Regulation (EU) 2023/1109 of 6 June 2023 granting a Union authorisation for the single biocidal product ‘APESIN Spray’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Regulation (EU) 2023/1108 of 6 June 2023 granting a Union authorisation for the single biocidal product ‘OP Plus’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Regulation (EU) 2023/1107 of 6 June 2023 granting a Union authorisation for the single biocidal product ‘Manorapid express’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Regulation (EU) 2023/1106 of 6 June 2023 granting a Union authorisation for the single biocidal product ‘Manorapid express GEL’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Regulation (EU) 2023/1105 of 6 June 2023 granting a Union authorisation for the single biocidal product ‘Superficid express WIPES’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Regulation (EU) 2023/1101 of 6 June 2023 refusing to authorise a health claim made on foods and referring to children’s development and health
Reglugerð framkvæmdastjórnarinnar (ESB) 2023/1101 frá 6. júní 2023 um synjun leyfis fyrir heilsufullyrðingu er varðar matvæli og vísar til þroskunar og heilbrigðis barna
Commission Implementing Decision (EU) 2023/1097 of 5 June 2023 not approving cyanamide as an existing active substance for use in biocidal products of product-types 3 and 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2023/1096 of 2 June 2023 laying down rules for the application of Directive 2013/29/EU of the European Parliament and of the Council as regards the regular collection and updating of data on accidents related to the use of pyrotechnic articles
Commission Implementing Regulation (EU) 2023/1091 of 5 June 2023 granting a Union authorisation for the single biocidal product ‘APESIN alcogel’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2023/1088 of 2 June 2023 postponing the expiry date of the approval of deltamethrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2023/1087 of 2 June 2023 postponing the expiry date of the approval of lambda-cyhalothrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2023/1086 of 2 June 2023 postponing the expiry date of the approval of metofluthrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2023/1085 of 2 June 2023 postponing the expiry date of the approval of Bacillus thuringiensis subsp. israelensis Serotype H14, Strain AM65-52 for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2023/1084 of 1 June 2023 on the unresolved objections regarding the conditions for granting an authorisation for the biocidal product A-Quasan in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Regulation (EU) 2023/1079 of 2 June 2023 approving (13Z)-hexadec-13-en-11-yn-1-yl acetate as an active substance for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2023/1079 frá 2. júní 2023 um að samþykkja (13Z)-hexadek-13-en-11-ýn-1-ýlasetat sem virkt efni til notkunar í sæfivörur í vöruflokki 19 í samræmi við reglugerð Evrópuþingsins og ráðsins (ESB) nr. 528/2012
Commission Implementing Regulation (EU) 2023/1078 of 2 June 2023 approving ozone generated from oxygen as an active substance for use in biocidal products of product-types 2, 4, 5 and 11 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2023/1078 frá 2. júní 2023 um að samþykkja óson, sem er búið til úr súrefni, sem virkt efni til notkunar í sæfivörur í vöruflokkum 2, 4, 5 og 11 í samræmi við reglugerð Evrópuþingsins og ráðsins (ESB) nr. 528/2012